• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

FDA approves generic ciprofloxacin injection

Article

The FDA has approved several abbreviated new drug applications for generic versions of ciprofloxacin injection for bacterial infections, including urinary tract infections.

The FDA has approved several abbreviated new drug applications for generic versions of ciprofloxacin injection for bacterial infections, including urinary tract infections.

Ciprofloxacin injection USP, 10 mg/mL, is packaged in 20-mL and 40-mL vials and a 120-mL pharmacy bulk package. The products are manufactured by multiple generic drug companies.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.